Skip to main navigation Skip to search Skip to main content

Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo

  • L. E. Finlan
  • , N. M. Kernohan
  • , G. Thomson
  • , P. E. Beattie
  • , T. R. Hupp
  • , S. H. Ibbotson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Phosphorylation of the tumour suppressor p53 by the CK2/FACT pathway plays a central role in suppressing ultraviolet (UV)-induced skin cancer in animal models. Although p53 protein stabilization is induced after solar-simulated irradiation of human skin in vivo, p53 phosphorylation has not been defined.
    Original languageEnglish
    Pages (from-to)1001-1010
    Number of pages10
    JournalThe British journal of dermatology
    Volume153
    Issue number5
    DOIs
    Publication statusPublished - Nov 2005

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Tumor Suppressor Protein p53
    • Skin
    • Apoptosis
    • Phosphorylation
    • DNA Damage
    • Humans
    • Photochemotherapy
    • Oxidative Stress
    • Cyclin-Dependent Kinase Inhibitor p21
    • PUVA Therapy
    • Keratinocytes
    • Aminolevulinic Acid

    Fingerprint

    Dive into the research topics of 'Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo'. Together they form a unique fingerprint.

    Cite this